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Malignant ﬁ  stula of the small bowel to the colon is rare and 
is most often due to adenocarcinoma. Small bowel lym-
phoma is unusual, representing less than 1 percent of all 
gastrointestinal malignancies. We report a case of intestinal 
lymphoma presenting with diarrhea and abdominal pain. A 
jejunocolic fistula was discovered during colonoscopy. Celi-
otomy revealed a large, ulcerated fistula tract between the 
jejunum and distal transverse colon, and pathology was con-
sistent with peripheral T-cell lymphoma. This is a rare entity 
in a nonimmunocompromised individual and has not been 
previously described in Korea. (Gut Liver 2011;5:387-390)
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INTRODUCTION
Enterocolic fistulas are usually caused by inflammatory 
conditions such as Crohn’s disease. It can also be caused by 
prior surgery, foreign bodies, pancreatitis, diverticulitis, and 
malignancy.
1-4 Small bowel tumors account for 1% to 3% of all 
gastrointestinal neoplasms.
5 Malignant lymphoma accounts for 
up to 20% of all primary malignant tumors of the small bowel,
6 
and most primary small intestine lymphomas are of B-cell ori-
gin. Lymphomas originating from T-cells are rare.
6,7 In Japan, 
only 24 cases of T-cell malignant lymphoma of the small intes-
tine have been reported and primary intestinal peripheral T-cell 
lymphoma (PTCL) is especially rare.
8 Intestinal fistula is known 
to be a late complication of primary intestinal lymphoma, and 
so is rarely encountered. This report describes a case-to our 
knowledge this is first reported case in Korean population-of 
primary intestinal PTCL causing jejunocolic fistula and perfora-
tion. 
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CASE REPORT 
A 56-year-old man presented with an acute diarrheal illness 
that had begun 14 days prior to first hospital visit. The patient 
had intermittent fevers, chills, night sweat 1 month previously 
and a 9 kg loss of body weight in the previous 3 months. The 
patient was afebrile and had stable hemodynamic vital signs. 
The patient was cachectic and pale, but appeared nontoxic on 
physical examination with a soft and flat abdomen, normoac-
tive bowel sounds and no tenderness or palpable lymphadenop-
athy. The past medical history was significant for pulmonary 
tuberculosis in the third decade of life and chronic hepatitis B 
carrier state. There was no prior history of abdominal surgery. 
Initial laboratory tests revealed the following results: leuko-
cyte counts 7.2×10
9/L (neutrophile 75.5%), Hemoglobin 11 g/
dL, platelets 407×10
9/L, total protein 6.6 g/dL, albumin 3.9 g/dL, 
total bilirubin 1.0 mg/dL, AST 73 IU/L, ALT 65 IU/L, Alkaline 
phosphatase 193 IU/L, LDH 212 IU/L, BUN 12.3 mg/dL, creati-
nine 0.96 mg/dL, sodium 129 mmol/L, potassium 3.3 mmol/L, 
Cl
- 93 mmol/L, plasma CEA 0.2 ng/mL, with a normal blood cell 
morphology. The work up for infectious diarrhea was negative. 
Contrast enhanced computed tomography (CT) of the abdomen 
showed focal wall thickening in the distal transverse colon with 
enlarged regional lymph nodes (Fig. 1). 
During the colonoscopy, a fistula opening communicating 
with a small bowel was identified at the distal transverse colon, 
and a circumferential ulcer was detected in the small bowel side 
through the fistula opening (Figs 2 and 3). The colonoscope 
was not advanced through the fistula due to the risk of perfora-
tion. Biopsies from the circumferential ulcer of small bowel side 
showed an aggregation of atypical lymphoid cells suggestive of 
lymphoma. However, biopsies from the margin of the colonic 
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Patient refused to admit and further evaluation until histo-
logic diagnosis of the lesion is determined. Therefore, the further 
studies including CT enterography and follow-up colonoscopy 
for additional biopsy were delayed. 
Two weeks after the colonoscopy, at his 3rd visit to outpatient 
clinic for admission, the patient presented with acute abdomi-
nal distress. An emergency laparotomy was performed, which 
revealed a large inflammatory mass-like lesion covered with 
omentum. After adhesiolysis, jejunocolic fistula and jejunoje-
junal adhesion were noted. A perforation site was found in the 
jejunocolic fistula. An extended right hemicolectomy and seg-
mental jejunectomy were performed with dissection of regional 
mesenteric lymph nodes.
Pathology revealed a 7.0×5.5 cm-sized ulcerated fistula tract 
between the jejunum and the distal transverse colon (Fig. 4). 
Light microscopy examination of the involved small intestinal 
mucosa showed diffuse infiltration of predominantly medium-
sized atypical lymphoid cells in the lamina propria (H&E stain, 
×400), but findings of normal small bowel mucosa showed 
normal villi without atrophic change. Immunohistochemical 
staining was positive for leukocyte common antigen, CD30, 
CD3, and Galectin-3; weakly positive for CD4; and negative for 
CD56, anaplastic lymphoma kinase, and CD8 (Fig. 5). Thirty of 
65 lymph nodes were also involved by atypical lymphoid cells. 
Thus, the final pathology was confirmed as unspecified primary 
small-intestinal PTCL.
After surgery, the patient’s condition continued to deteriorate 
and he died 2 months after surgery due to peritonitis and sepsis. 
Fig. 1. Contrast enhanced computed tomography of the abdomen 
shows focal wall thickening in distal transverse colon (white arrow) 
with enlarged regional lymph nodes.
Fig. 2. Colonoscopic examination reveals a fistula opening at the dis-
tal transverse colon.
Fig. 3. Colonoscopic examination reveals circumferential ulcer and 
fistula tract at the small bowel.
Fig. 4. Pathology reveals a 7.0×5.5 cm-sized ulcerated fistula tract 
opening (white arrow) between the jejunum and the distal transverse 
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DISCUSSION
The gastrointestinal tract is the most frequent site of extra-
nodal involvement in malignant lymphoma. However, primary 
gastrointestinal lymphoma remains relatively rare. Gastroin-
testinal lymphomas represent 1% to 10% of all gastrointestinal 
malignancies,
9,10 up to 20% of all small bowel malignancies
5,6 
and only 0.2% to 0.4% of large bowel malignancies.
11 Most 
primary small intestine lymphomas originate from B-cells, with 
T-cell origin being rare.
6,7 The most common location of PTCL is 
the jejunum
12 and common symptoms include abdominal pain, 
nausea, vomiting, diarrhea, fatigue, weight loss and fever. Un-
fortunately, these symptoms are not disease specific. Therefore, 
the diagnosis of lymphoma of the small intestine is often made 
after complications such as hemorrhage, obstruction or perfora-
tion develop.
6,13
Enterocolic fistula is a rare complication in patients with 
intestinal lymphoma. It has been noted that most gastrointesti-
nal malignant fistulas arise in the presence of locally invading 
adenocarcinoma.
14 In the natural course of PTCL, enterocolic 
fistula is likely to represent a late complication and suggests an 
advanced disease.
15 
To the best of our knowledge, only six cases enterocolic 
fistula associated with lymphoma have previously reported in 
the English literatures. Of these, four were B-cell lymphoma
15-18 
and two cases were T-cell lymphoma.
9,19 In all six cases, diar-
rhea was an initial symptom. There has been no other case of 
intestinal lymphoma causing alimentary tract fistula reported in 
Korea. 
The present patient also presented with watery diarrhea with 
nonspecific and vague abdominal pain. Although the patient 
already had intestinal adhesion and enterocolic fistula at the 
time of the first hospital visit, physical examination revealed no 
abdominal tenderness or palpable abdominal mass. Fever, night 
sweat and extensive weight loss were the only clues to suspect 
a malignant disease. The patient’s diarrhea may be explained 
by short bowel syndrome and small bowel bacterial overgrowth 
syndrome caused by refluxed colonic bacteria.
20,21 In summary 
of the symptoms above, fever and extensive weight loss were 
clinical clues to the diagnosis of malignant disease. Subacute di-
arrhea that was intractable with the conventional antidiarrheal 
agent and negative stool studies were clues to presume an in-
Fig. 5. Results of H&E staining of tumor cells (×400). Diffuse infiltration of medium to large lymphoid cells with pleomorphic and irregular nuclei 
is noted (A). Tumor cells are strongly positive for CD3 (B), weakly positive for CD4 (C), and strongly positive for LCA (D).390  Gut and Liver, Vol. 5, No. 3, September 2011
testinal fistula. Barium studies, endoscopy and CT enterography 
are useful tools for demonstrating a fistulous tract. 
The treatment options for intestinal lymphoma are varied and 
not standardized. Resection of tumor and regional lymph nodes 
constitutes the initial treatment of small bowel lymphoma. After 
surgery, combination chemotherapy is the preferred option.
22   
In comparison with B-cell lymphoma, PTCL is a heterogeneous 
group of neoplasms presenting as advanced disease, and is 
characterized by widespread dissemination, aggressive behavior 
and a very poor outcome.
23 The therapeutic outcome of PTCL is 
usually worse than that of diffuse large B-cell lymphoma.
24 
In conclusion, we report a male patient with primary intesti-
nal PTCL complicated with enterocolic fistula and small bowel 
peforation. Although intestinal PTCL is an extremely rare dis-
ease, particular attention should be paid its nonspecific clinical 
manifestation for early diagnosis and treatment of this aggres-
sive disease.
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